Forepont Capital Partners
Forepont Capital Partners is a venture capital firm founded in 2014 and based in New York, with additional offices in London and Paris. The firm specializes in investing in early-stage companies, primarily in series A and B funding rounds, with a strong focus on the healthcare sector, including biotech, medtech, life sciences, and technology. Forepont seeks to support innovative initiatives that create both impact and performance, investing in areas such as genomics, imaging, biomarkers, systems therapeutics, data, wearables, and mobile applications. The firm's investment strategy encompasses opportunities in France, Europe, and the United States, reflecting a commitment to fostering advancements in various health-related technologies.
Developer of vaccines intended to offer protection against pneumococcal bacteria, the world's foremost bacterial pathogen. The company's vaccine is developed by using a gamma-irradiation process that inactivates and kills the bacteria while leaving the surface protein antigens intact thereby conferring improved immunity against Streptococcus pneumoniae, enabling patients the chance of improved immunity against streptococcus pneumoniae.
BayBridgeDigital Group LLC is a digital advisory and consulting firm headquartered in New York, with additional offices in Paris and Tel Aviv. Established in 2017, the company specializes in digital transformation services that encompass e-commerce, digital marketing, mobile solutions, business insights and analytics, artificial intelligence, Salesforce integration, and software development. BayBridgeDigital serves a range of industries, including retail, energy, healthcare, and banking. The firm utilizes design-led approaches and the Salesforce ecosystem to drive digital transformations, helping clients achieve business value more quickly while enhancing customer experiences and operational efficiency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.